On April 22, 2023, we hosted a virtual Rebirthday Celebration, occurring every April, Donate Life Month, for 20 years to celebrate […]
Join us for a timely CME session available on-demand with leading oncologists to examine the latest diagnostic and treatment strategies for hepatocellular carcinoma (HCC).
ALF hosted our Autoimmune Liver Disease Summit Forum: Breaking Down Barriers on March 15th and 16th 2023. This recording is of […]
Dr. Heller is Chief of the translational Hepatology section at the National Institute of Health where he focuses on rare liver […]
If you or someone you love has liver cancer, please join the ALF New England Medical Advisory Council for an interactive […]
We discussed emerging therapies in Biliary Atresia and other pediatric cholestatic diseases with Dr. Jaime Chu. Dr. Chu is the Mount […]
Biliary atresia (BA) is a rare disease at birth causing damage, scarring and blockage of the bile ducts. Biliary atresia (BA) is most commonly seen in full-term infants, (not in premature babies). Treatment of BA is surgical, and outcomes are better if the diagnosis and surgery occurs early, before 40 days of life. View this brief video about BA made just for parents.
During this program, we explored what clinical trials consist of and shared information so that you can make an informed decision […]
ALF presents Liver Cancer 101 presented by Tamar Taddei, MD as part of the 2022 Liver Cancer Conference. Last updated on […]
ALF presents How to Navigate Clinical Trials presented by Renu Dhanasekaran, MD as part of the 2022 Liver Cancer Conference. Last […]
ALF presents Healthy Eating for People with Cancer presented by Dr. Nisha Patel as part of the 2022 Liver Cancer Conference. […]
ALF presents Liver Cancer Transplant Options presented by Ali Zarrinpar, MD as part of the 2022 Liver Cancer Conference. Last updated […]